Clinical characteristics of the asthma–COPD overlap syndrome – a systematic review
Open Access
- 1 July 2015
- journal article
- review article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 10 (1) , 1443-1454
Abstract
Background and objective: In recent years, the so-called asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) has received much attention, not least because elderly individuals may present characteristics suggesting a diagnosis of both asthma and COPD. At present, ACOS is described clinically as persistent airflow limitation combined with features of both asthma and COPD. The aim of this paper is, therefore, to review the currently available literature focusing on symptoms and clinical characteristics of patients regarded as having ACOS. Methods: Based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, a systematic literature review was performed. Results: A total of 11 studies met the inclusion criteria for the present review. All studies dealing with dyspnea (self-reported or assessed by the Medical Research Council dyspnea scale) reported more dyspnea among patients classified as having ACOS compared to the COPD and asthma groups. In line with this, ACOS patients have more concomitant wheezing and seem to have more cough and sputum production. Compared to COPD-only patients, the ACOS patients were found to have lower FEV1% predicted and FEV1/FVC ratio in spite of lower mean life-time tobacco exposure. Furthermore, studies have revealed that ACOS patients seem to have not only more frequent but also more severe exacerbations. Comorbidity, not least diabetes, has also been reported in a few studies, with a higher prevalence among ACOS patients. However, it should be acknowledged that only a limited number of studies have addressed the various comorbidities in patients with ACOS. Conclusion: The available studies indicate that ACOS patients may have more symptoms and a higher exacerbation rate than patients with asthma and COPD only, and by that, probably a higher overall respiratory-related morbidity. Similar to patients with COPD, ACOS patients seem to have a high occurrence of comorbidity, including diabetes. Further research into the ACOS, not least from well-defined prospective studies, is clearly needed.Keywords
This publication has 29 references indexed in Scilit:
- Diagnosis and Pharmacotherapy of Stable Chronic Obstructive Pulmonary Disease: The Finnish GuidelinesBasic & Clinical Pharmacology & Toxicology, 2015
- The chronic obstructive pulmonary disease‐asthma overlap syndromeAllergy and Asthma Proceedings, 2015
- The asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS)Current Opinion in Pulmonary Medicine, 2015
- Asthma control in elderly asthmatics. An Italian observational studyRespiratory Medicine, 2014
- Characteristics and self-rated health of overlap syndromeInternational Journal of Chronic Obstructive Pulmonary Disease, 2014
- The clinical and genetic features of COPD-asthma overlap syndromeEuropean Respiratory Journal, 2014
- Chronic Obstructive Pulmonary Disease and Asthma–Patient Characteristics and Health ImpairmentCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2013
- Challenges of COPD diagnosisExpert Opinion on Medical Diagnostics, 2013
- A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)Primary Care Respiratory Journal, 2013
- High hospital burden in overlap syndrome of asthma and COPDThe Clinical Respiratory Journal, 2013